Health - HealthQuill

As cities light up during the night, the pollution caused by the illumination sets an ‘ecological trap’ for migratory birds causing them to collide with glass buildings leading to their death, a study finds.

Urban lights are death traps for migratory birds in the US: Study

HQ Team December 5, 2023: As cities light up during the night, the pollution caused by the illumination sets an ‘ecological trap’ for.

by HealthQuill
December 5, 2023
0 Comments

Pneumonia is a form of acute respiratory infection that affects the lungs and kills more children than any other infectious disease. Every day at least one child dies from pneumonia every 43 seconds, according to UNICEF.

Drugs Health Pharma

Opinion: Steps for prevention, spread, and monitoring pneumonia

By K. Leelamoni November 5, 2023: Outbreaks of pneumonia affecting children in parts of northern China, the US, the Netherlands, and Denmark are higher than.

by HealthQuill
December 5, 2023
5 Comments

Fluorescent staining reveals the extensive network of blood vessels of the dura mater. These vessels contain T cells that, in a mouse model of chronic high blood pressure, become activated and produce conditions that can lead to dementia-like symptoms.Image courtesy of the Iadecola lab.

Drugs Health Pharma

Abnormal brain cell activation in high BP patients linked to dementia

HQ Team December 5, 2023: The response of immune cells inside the protective covering of the brain may lead to a cognitive decline.

by HealthQuill
December 5, 2023
0 Comments

US-based Pacific Northwest National Laboratory, Microsoft Corp., and Micron Technology have joined hands to make computational chemistry available to researchers and industrial users.

Drugs Health Pharma

Roche forays into weight-loss therapy, buys Carmot for $2.7 billion

HQ Team December 4, 2023: In a strategic push into the obesity and diabetes treatment market, Roche, a leading pharmaceutical company, has finalized.

by HealthQuill
December 4, 2023
0 Comments

The COP28 has unveiled a $1.7 billion funding plan to meet climate and diversity goals.

Climate Health Pharma

COP28: $1.7 billion plan to protect climate, diversity goals unveiled

HQ Team December 4, 2023: The COP28 has unveiled a $1.7 billion funding plan to meet climate and diversity goals. The key objectives.

by HealthQuill
December 4, 2023
0 Comments

Eli Lilly and Company got a second accelerated approval from the Food and Drug Administration for its blood cancer drug Jaypirca.

Drugs Health Pharma

Eli Lilly’s drug gets second FDA nod for treating blood cancer in adults

HQ Team December 4, 2023: Eli Lilly and Company got a second accelerated approval from the Food and Drug Administration for its blood.

by HealthQuill
December 4, 2023
0 Comments

Semaglutide based weightloss drugs tied to increased suicide risk in a new study

Drugs Health Pharma

EMA expands probe into suicidal thoughts linked to weight loss drugs

HQ Team December 2, 2023: The European Medicines Agency (EMA) is intensifying its investigation into the potential link between certain GLP-1 receptor agonist.

by HealthQuill
December 2, 2023
2 Comments

A clutch of 41 multilateral development banks, funders, countries and philanthropies announced a global funding plan to cut greenhouse gas emissions and to protect people from climate risks to health.

Climate Health Pharma

COP28: Funding pathway to cut emissions, protect people from risks

HQ Team November 2, 2023: A clutch of 41 multilateral development banks, funders, countries and philanthropies announced a global funding plan to cut.

by HealthQuill
December 2, 2023
0 Comments

Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50% of the patients opted out due to adverse effects of the medicine.

Drugs Health Pharma

Pfizer Inc., stops twice-daily oral obesity drug trial at mid-stage

HQ Team December 2, 2023: Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50%.